Autologous Cell Therapy Market by Therapy, Application, and Geography - Forecast and Analysis 2020-2024

  • Published: Apr 2020
  • Pages: 120
  • SKU: IRTNTR41330

The 2021-2025 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The autologous cell therapy market size has the potential to grow by USD 1.97 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period.

This report provides a detailed analysis of the market by therapy (autologous stem cell therapy and autologous cellular immunotherapies), application (oncology, musculoskeletal disorders, and dermatology), and geography (North America, APAC, Europe, South America, and MEA). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Bayer AG, Brainstorm Cell Therapeutics Inc., Daiichi Sankyo Co. Ltd., FUJIFILM Holdings Corp., Holostem Terapie Avanzate Srl, Osiris Therapeutics Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Sumitomo Chemical Co. Ltd., and Vericel Corp.

Market Overview

autologous-cell-therapy-market-size

Browse TOC and LoE with selected illustrations and example pages of autologous cell therapy market

Request a FREE sample now!

Market Competitive Analysis

The market is fragmented and is been witnessing an increasing number of M&As and strategic alliances. This will lead to new product development and increase product variety, significantly impacting the market growth. Osiris Therapeutics Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Sumitomo Chemical Co. Ltd., and Vericel Corp. are some of the major market participants. Although the increasing demand for effective drugs for cardiac and degenerative disorders will offer immense growth opportunities, critical ethical challenges with respect to stem cell research will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this autologous cell therapy market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this market analysis report also provides information on the upcoming autologous cell therapy market trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This autologous cell therapy market analysis report provides information on the production, sustainability, and prospects of several leading companies, including:

  • Bayer AG
  • Brainstorm Cell Therapeutics Inc.
  • Daiichi Sankyo Co. Ltd.
  • FUJIFILM Holdings Corp.
  • Holostem Terapie Avanzate Srl
  • Osiris Therapeutics Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Sumitomo Chemical Co. Ltd.
  • Vericel Corp.

Autologous Cell Therapy Market: Segmentation by Region

autologous-cell-therapy-market-share-by-region

For more insights on the market share of various regions Request for a FREE sample now!

North America was the largest autologous cell therapy market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The increasing demand for stem cell therapy products and the rising investments in R&D activities will significantly drive autologous cell therapy market growth in this region over the forecast period.

Over 44% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for autologous cell therapy in North America. Market growth in this region will be slower than the growth of the market in APAC.

Autologous Cell Therapy Market: Segmentation by Therapy

autologous-cell-therapy-market-share-by-distribution-channel

Request for a FREE sample and Get more information on the market contribution of various segments

Autologous stem cell therapy is preferred in certain treatments such as solid tumors, including sarcoma, lymphoma, brain tumors, and neuroblastoma. It is also used in cases when surgeries are performed on the heart, blood vessels, and the urinary tract. One advantage of autologous stem cell therapy is that the body recognizes the cells and, therefore, does not reject or attack them. These factors are driving the autologous cell therapy market growth by the autologous stem cell therapy segment.

The autologous cell therapy market share growth by the autologous stem cell therapy segment will be faster than the growth of the market by the autologous cellular immunotherapies segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the autologous cell therapy market size.

Autologous Cell Therapy Market: Key Drivers and Trends

The autologous cell therapy market will register a CAGR of almost 22% during the forecast period. The increasing demand for effective drugs for cardiac and degenerative disorders will be one of the factors driving the growth prospects for the market until 2024. The increasing demand for effective drugs for cardiac and degenerative disorders across the world has encouraged the discovery of possible cardiac autologous cells.

These cells are used to repair damaged cardiac tissue cells caused by acute myocardial infarction or coronary artery disease. For instance, Mesoblast is developing MPC-150-IM for the treatment of advanced and end-stage chronic heart failure. The focus of numerous players towards launching similar products for the treatment of cardiac disorders will significantly influence autologous cell therapy market growth.

autologous-cell-therapy-market-report

Request for a FREE sample now!

Autologous Cell Therapy Market: Key Highlights of the Report for the Forecast Period 2020-2024

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will drive autologous cell therapy market growth during the next five years
  • Precise estimation of the autologous cell therapy market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the autologous cell therapy industry across North America, APAC, Europe, South America, and MEA
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of autologous cell therapy market vendors 

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The autologous cell therapy market growth will increase by $1969.86 million during 2019-2024.
The autologous cell therapy market is expected to grow at a CAGR of 21.80% during 2019-2024.
Technavio has segmented the autologous cell therapy market by other 1 (Autologous stem cell therapy and Autologous cellular immunotherapies) ,application (Transportation, Machinery, Metal fabrication, Consumer goods, and Others) , and geographic (North America, Europe, APAC, and South America).
Bayer AG, Brainstorm Cell Therapeutics Inc., Daiichi Sankyo Co. Ltd., FUJIFILM Holdings Corp., Holostem Terapie Avanzate Srl, Osiris Therapeutics Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Sumitomo Chemical Co. Ltd., Vericel Corp. are a few of the key vendors in the autologous cell therapy market.
North America will register the highest growth rate of 46.77% among the other regions. Therefore, the autologous cell therapy market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the autologous cell therapy market growth are:
  • Increasing demand for effective drugs for cardiac and degenerative disorders
  • Use of biomass as a fuel in boiler
The autologous cell therapy market vendors should focus on grabbing business opportunities from the autologous stem cell therapy segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted

Single User:

2500 USD

Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase

Technavio's SUBSCRIPTION platform

Register for a free trial today and gain instant access to 17,000+ market research reports.

START YOUR FREE TRIAL

Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report

"What other custmores say"

17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>